A Population-Based Study of Genes Previously Implicated in Breast CancerChunling Hu, Celine M. Vachon, Nicholas Boddicker et al.|New England Journal of Medicine|2021Cited by 862
Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers: The PROSE Study GroupTimothy R. Rebbeck, Barbara Weber, Tara M. Friebel et al.|Journal of Clinical Oncology|2005Cited by 406
Germline Mutation in <i>BRCA1</i> or <i>BRCA2</i> and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian CancerFrancisco José Cândido dos Reis, Honglin Song, Ellen L. Goode et al.|Clinical Cancer Research|2014Cited by 160
Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2Kathryn J. Ruddy, Valentina Silvestri, Daniel Barrowdale et al.|Breast Cancer Research|2016Cited by 118
Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association ConsortiumDieter Flesch‐Janys, Jieping Lei, Anja Rudolph et al.|Human Genetics|2015Cited by 10